Next Article in Journal
Lung Cancer Gene Signatures and Clinical Perspectives
Next Article in Special Issue
Copy Number Variation in Chickens: A Review and Future Prospects
Previous Article in Journal / Special Issue
Copy Number Studies in Noisy Samples
Article Menu

Export Article

From the third issue of 2017, Microarrays has changed its name to High-Throughput.

Open AccessReview
Microarrays 2013, 2(4), 304-317;

Chromosomal Microarrays in Prenatal Diagnosis: Time for a Change of Policy?

Medical Genetics, Department of Biomedicine, University Hospital Basel, Burgfelderstr. 101, Building J, CH-4055 Basel, Switzerland
Ultraschall Freie Strasse, Freie Strasse 38, CH-4001 Basel, Switzerland
Department of Medical Genetics, Box 153, BC Children's and Women's Hospital, 4480 Oak Street, Vancouver BC, V6H 3V4, Canada
Author to whom correspondence should be addressed.
Received: 22 October 2013 / Revised: 19 November 2013 / Accepted: 27 November 2013 / Published: 5 December 2013
Full-Text   |   PDF [185 KB, uploaded 5 December 2013]   |  


Microarrays have replaced conventional karyotyping as a first-tier test for unbalanced chromosome anomalies in postnatal cytogenetics mainly due to their unprecedented resolution facilitating the detection of submicroscopic copy number changes at a rate of 10–20% depending on indication for testing. A number of studies have addressed the performance of microarrays for chromosome analyses in high risk pregnancies due to abnormal ultrasound findings and reported an excess detection rate between 5% and 10%. In low risk pregnancies, clear pathogenic copy number changes at the submicroscopic level were encountered in 1% or less. Variants of unclear clinical significance, unsolicited findings, and copy number changes with variable phenotypic consequences are the main issues of concern in the prenatal setting posing difficult management questions. The benefit of microarray testing may be limited in pregnancies with only moderately increased risks (advanced maternal age, positive first trimester test). It is suggested to not change the current policy of microarray application in prenatal diagnosis until more data on the clinical significance of copy number changes are available. View Full-Text
Keywords: microarrays; array CGH; prenatal diagnosis microarrays; array CGH; prenatal diagnosis

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Miny, P.; Wenzel, F.; Tercanli, S.; Filges, I. Chromosomal Microarrays in Prenatal Diagnosis: Time for a Change of Policy? Microarrays 2013, 2, 304-317.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics



[Return to top]
Microarrays EISSN 2076-3905 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top